| 1 |
Teixeira MVS, Aldana-mejía JA, da Silva Ferreira ME, Furtado NAJC. Lower Concentrations of Amphotericin B Combined with Ent-Hardwickiic Acid Are Effective against Candida Strains. Antibiotics 2023;12:509. [DOI: 10.3390/antibiotics12030509] [Reference Citation Analysis]
|
| 2 |
Liu H, Zhang K, Jang YO, Qiao Z, Jin J, Thi Dao TN, Koo B, Park CO, Shin Y. Homobifunctional imidoester-modified zinc nano-spindle attenuated hyphae growth of Aspergillus against hypersensitivity responses. iScience 2023;26:105922. [PMID: 36866037 DOI: 10.1016/j.isci.2022.105922] [Reference Citation Analysis]
|
| 3 |
Bauer KA, Puzniak LA, Yu KC, Finelli L, Moise P, Ai C, Watts JA, Gupta V. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation. BMC Infect Dis 2022;22:841. [DOI: 10.1186/s12879-022-07810-8] [Reference Citation Analysis]
|
| 4 |
Shah NN, Khan Z, Ahad H, Elderdery AY, Alomary MN, Atwah B, Alhindi Z, Alsugoor MH, Elkhalifa AM, Nabi S, Bashir SM, Yaqub T, Rather GA, Ansari MA. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review. Journal of Infection and Public Health 2022;15:1299-1314. [DOI: 10.1016/j.jiph.2022.10.011] [Reference Citation Analysis]
|
| 5 |
Goyal P, Sikary AK, Sachdeva RA, Parashar L, Tarique A. Mortality analysis of COVID-19 cases during the second wave and its comparison with the first wave: A hospital-based study. J Family Med Prim Care 2022;11:6091-5. [PMID: 36618203 DOI: 10.4103/jfmpc.jfmpc_341_22] [Reference Citation Analysis]
|
| 6 |
Hure E, Camí G, Mosconi N, Raimondi M, Rizzotto M. Synthesis, characterization, lipophilicity and antifungal properties of three new complexes of sulfamerazine (HSMR) with Ag(I): [Ag(SMR)], [Ag2(SMR)SCN] and [Ag(SMR)o-phenanthroline]. Polyhedron 2022;223:115979. [DOI: 10.1016/j.poly.2022.115979] [Reference Citation Analysis]
|
| 7 |
Averyanov AV, Danilevskaya OV. Diffuse Lung Disease in Convalescents of COVID-19. Her Russ Acad Sci 2022;92:412-417. [DOI: 10.1134/s1019331622040037] [Reference Citation Analysis]
|
| 8 |
Davies GE, Thornton CR. Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans. JoF 2022;8:756. [DOI: 10.3390/jof8070756] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Nazari T, Sadeghi F, Izadi A, Sameni S, Mahmoudi S. COVID-19-associated fungal infections in Iran: A systematic review. PLoS ONE 2022;17:e0271333. [DOI: 10.1371/journal.pone.0271333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Bryant JA, Riordan L, Watson R, Nikoi ND, Trzaska W, Slope L, Tibbatts C, Alexander MR, Scurr DJ, May RC, de Cogan F. Developing Novel Biointerfaces: Using Chlorhexidine Surface Attachment as a Method for Creating Anti‐Fungal Surfaces. Global Challenges. [DOI: 10.1002/gch2.202100138] [Reference Citation Analysis]
|
| 11 |
Garre V. Recent Advances and Future Directions in the Understanding of Mucormycosis. Front Cell Infect Microbiol 2022;12:850581. [DOI: 10.3389/fcimb.2022.850581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Schwarz P, Nikolskiy I, Bidaud A, Sommer F, Bange G, Dannaoui E. In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections. JoF 2022;8:115. [DOI: 10.3390/jof8020115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Basile K, Halliday C, Kok J, Chen SC. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients. JoF 2022;8:58. [DOI: 10.3390/jof8010058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
